34 related articles for article (PubMed ID: 12407485)
21. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).
Squires KE; Gulick R; Tebas P; Santana J; Mulanovich V; Clark R; Yangco B; Marlowe SI; Wright D; Cohen C; Cooley T; Mauney J; Uffelman K; Schoellkopf N; Grosso R; Stevens M
AIDS; 2000 Jul; 14(11):1591-600. PubMed ID: 10983646
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).
Joly V; Flandre P; Meiffredy V; Brun-Vezinet F; Gastaut JA; Goujard C; Remy G; Descamps D; Ruffault A; Certain A; Aboulker JP; Yeni P;
Antimicrob Agents Chemother; 2002 Jun; 46(6):1906-13. PubMed ID: 12019107
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).
Lowe SH; Wensing AM; Hassink EA; ten Kate RW; Richter C; Schreij G; Koopmans PP; Juttmann JR; van der Tweel I; Lange JM; Borleffs JC
HIV Clin Trials; 2005; 6(5):235-45. PubMed ID: 16306030
[TBL] [Abstract][Full Text] [Related]
24. Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients.
Sension MG; Bellos NC; Johnson J; Sepulveda GE; DeJesus E; Santana JL; Ames MH; Goodwin SD
HIV Clin Trials; 2002; 3(5):361-70. PubMed ID: 12407485
[TBL] [Abstract][Full Text] [Related]
25. Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.
Cruciani M; Mengoli C; Serpelloni G; Parisi SG; Malena M; Bosco O
Cochrane Database Syst Rev; 2013 Jun; (6):CD008270. PubMed ID: 23740608
[TBL] [Abstract][Full Text] [Related]
26. Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.
Rutherford GW; Sangani PR; Kennedy GE
Cochrane Database Syst Rev; 2003; (4):CD002037. PubMed ID: 14583945
[TBL] [Abstract][Full Text] [Related]
27. Low dose versus high dose stavudine for treating people with HIV infection.
Magula N; Dedicoat M
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007497. PubMed ID: 25627012
[TBL] [Abstract][Full Text] [Related]
28. Protease inhibitor-sparing regimens.
Smith KY
J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):116-20. PubMed ID: 12942669
[No Abstract] [Full Text] [Related]
29. Fat redistribution in indinavir-treated patients with HIV infection: A review of postmarketing cases.
Benson JO; McGhee K; Coplan P; Grunfeld C; Robertson M; Brodovicz KG; Slater E
J Acquir Immune Defic Syndr; 2000 Oct; 25(2):130-9. PubMed ID: 11103043
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]